Drug intelligence / Profile preview

HXJD

Development stage: Preclinical
Lead developer: Beijing municipal administration of traditional Chinese medicine and China-Japan friendship hospital
Administration: Oral

Overview

HXJD formula, also known as 活血解毒汤 (Huoxue Jiedu Tang), is a Traditional Chinese Medicine (TCM) oral formula being investigated for the treatment of plaque psoriasis. Its name translates to "Blood-activating and Detoxifying Decoction," suggesting its therapeutic actions in TCM involve promoting blood circulation, resolving blood stasis, clearing heat, and eliminating toxins, which are believed to contribute to the pathogenesis of psoriasis in TCM theory. It is administered orally and has been studied in clinical trials in combination with fire-needle therapy and Vaseline cream for psoriasis.

Other names: HXJD formula活血解毒汤

Beyond the preview

Go deeper on HXJD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HXJD.

Explore the full profile